Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Endo Pharmaceuticals to Pay $180M in a Licensing and Development Agreement for BioDelivery Sciences International Pain Treatment
Endo Pharmaceuticals to Pay $180M in a Licensing and Development Agreement for BioDelivery Sciences International Pain Treatment
Endo Pharmaceuticals to Pay $180M in a Licensing and Development Agreement for BioDelivery Sciences International Pain Treatment
Submitted by
admin
on January 7, 2012 - 1:35pm
Source:
Becker's Orthopedic and Spine
News Tags:
BioDelivery Sciences
Endo
pain management
buprenorphine
Headline:
Endo Pharmaceuticals to Pay $180M in a Licensing and Development Agreement for BioDelivery Sciences International Pain Treatment
Do Not Allow Advertisers to Use My Personal information
